Cellectar Biosciences, Inc. Annual report pursuant to Section 13 and 15(d)

STOCKHOLDERS' EQUITY (Details 1) - shares	12 Months Ended
STOCKHOLDERS' EQUITY (Details 1) - shares	Dec. 31, 2016	Dec. 31, 2015
Number Of Shares Reserved For Future Issuance	12,321,724	932,230
Preferred Stock [Member]
Number Of Shares Reserved For Future Issuance	1,133,339	0
Warrant [Member]
Number Of Shares Reserved For Future Issuance	10,716,952	861,314
Stock options [Member]
Number Of Shares Reserved For Future Issuance	471,433	70,916